Abed Kayyal

New technological developments in biotechnology are creating new opportunities for less centralized production and distribution of biological medicines, including vaccines. This case explores how innovative small-scale production technologies in biotech enable more flexible production of vaccines and other biologic medicines in low- or middle-income countries (LMICs) and neighboring countries.

Published 26 Jan 2024

Reference 6850

Topic Operations

Industry Biotechnology

Region Africa

View case
Vaccine Supply Chains, Humanitarian Logistics, Innovation, Circular Economy